Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Dry powder inhaler (DPI) products have traditionally comprised a simple formulation of
micronised drug mixed with a carrier excipient, typically lactose monohydrate. The presence …

Nanocarriers can deliver drugs to specific organs or cells, potentially bridging the gap
between a drug's function and its interaction with biological systems such as human …

Superparamagnetic iron oxide nanoparticles (SPIONs) have been widely employed in
biomedical fields, including targeted delivery of antitumor therapy. Conventional magnetic …

Lung cancer is the second most prevalent and the deadliest among all cancer types.
Chemotherapy is recommended for lung cancers to control tumor growth and to prolong …

Dry powder inhaler (DPI) is an attractive dosage form for local and systemic pulmonary drug
delivery. However, designing DPIs with adequate physicochemical properties is …

For the past few years, there has been significant research in the area of nanotechnology
using nanoparticles. In the field of modern material science, inorganic nanoparticles are …

Administration of drugs via inhalation can overcome issues related to poor water solubility,
low absorption or bioavailability associated with oral administration. In the current study we …

Targeted drug delivery to solid tumors is a very active research area, focusing mainly on
improved drug formulation and associated best delivery methods/devices. Drug-targeting …

Nanocarriers have been increasingly proposed for lung drug delivery applications. The
strategy of combining the intrinsic and more general advantages of the nanostructures with …